CD274 and renal cell carcinoma: PD-L1 expression may also be a valuable predictive factor for anti PD-1/PDL-1 therapy, as shown in another recently published meta-analysis involving 4063 cases RCC patients randomized to anti PD-1/PDL-1 agent vs. sunitinib.